Health

U.S. drugmaker Eli Lilly plans to launch Mounjaro, its blockbuster diabetes treatment and hugely popular obesity drug, in India as early as next year, CEO

South Korea will send its military and community doctors to hospitals in the coming days following a massive strike by junior doctors, Prime Minister Han

New Zealand will on Tuesday repeal the world’s first law banning the sale of tobacco to future generations, the government said, despite researchers and campaigners

British medical device maker Smith+Nephew on Tuesday forecast improved profitability this year after broadly meeting market expectations for earnings in 2023, driven by strong growth

Japan’s Takeda Pharmaceutical will increase production of its dengue vaccine Qdenga through a partnership with Indian vaccine maker Biological E., the two companies announced.

British drugmaker GSK said its oral drug to treat gonorrhoea has achieved a key goal of staying ahead of existing combination drugs in late-stage trials.

Xolar, an asthma drug marketed 20 years ago by Roche and Novartis significantly reduced allergic reactions in people with multiple severe food allergies in a

South Korea’s government told junior doctors on Monday they had until the end of February to return to work or risk being punished for staging

Pharmaceutical companies last year launched new drugs in the U.S. at prices 35% higher than in 2022, partly reflecting the industry’s use of expensive treatments

The European medicines regulator on Friday recommended granting Biogen’s registration certificate to a drug for the deadly and progressive neurodegenerative disease known as amyotrophic lateral